Articles |

The Evolution of Therapy for Patients With Stage IIIA (N2) Lung Cancer FREE TO VIEW

David H. Harpole, Jr.
Author and Funding Information

From the Duke Thoracic Oncology Program, Duke University Comprehensive Cancer Center, Durham, NC.

1997 by the American College of Chest Physicians

Chest. 1997;112(4_Supplement):201S-202S. doi:10.1378/chest.112.4_Supplement.201S
Text Size: A A A
Published online


This is a demonstrable case report and discussion of recent trends in neoadjuvant therapy for patients with locally advanced stage IIIA (N2) non-small cell lung cancer.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543